跳至主要内容
临床试验/NL-OMON41034
NL-OMON41034已完成4 期

Registry of the treatment of primary insufficiency of the great saphenous vein with a diameter >/= 12 mm, antero-lateral branches, or great saphenous vein insufficiency below the knee with mechano-chemical endovenous ablation (MOCA) - MOCA-X

Rijnstate Ziekenhuis0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Symptomatic varicose veins, C3-C5
  • 2. Ultrasound criteria:
  • a. Diameter supragenual great saphenous vein (GSV) >/= 12 mm , not tortuous; or
  • b. Insufficient antero-lateral branch <12 mm; or
  • c. Insufficient below knee GSV < 12 mm
  • 3. Signed informed consent
  • 4. Patient consents to follow-up
  • 5. Age > 18 year en < 80 year

排除标准

  • 1. Patient is not capable to provide informed consent
  • 2. Pregnancy and lactation
  • 3. C6 varicose veins
  • 4. Previous surgery or endovenous ablation at to treated segment
  • 5. Deep venous vein thrombosis in medical history
  • 6. Oral anti-coagulant therapy
  • 7. Contra-indications or allergy for sclerosant
  • 8. Immobilisation
  • 9. Coagulant disorders or increaased risk for thrombo-embolic complications: known coagulant disorders such as hemofilia A, hemofilia B, Von Willebrand disease, Glanzmann disease, factor VII-deficiency, idiopathic thrombo-cytopenic purpura, factor V Leiden disease and deep venous thrombosis or lung emboli in medical history
  • 10. Fontaine III of IV peripheral arterial disease
  • 11. Severe kidney disease: known GFR < 30 ml/min.
  • 12. Liver diseases accompanied by changes in coagulation of the blood, anamnistic indications for tendency towards haemorrhage , such as epistaxis and spontanuous hematoma, known liver cirrhosis.

研究者

发起方
Rijnstate Ziekenhuis

相似试验

Registry of the treatment of primary insufficiency... | 临床试验